GE HealthCare Technologies Inc
GE HealthCare Technologies Inc (GEHC) Covered Calls
As of September 24, 2026, GEHC has 113 covered call opportunities in the coming three months. Return ranges from 1.6 to 74.8% until expiration. Annualized return ranges from 10.5 to 541.2%. The nearest expiration is September 25, 2026. Maximum potential profit is $4,946.
Read more
Running GEHC covered calls helps you generate consistent income from GE HealthCare Technologies Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on GE HealthCare Technologies Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best GEHC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if GEHC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling GEHC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given GE HealthCare Technologies Inc covered call is worth writing.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products.
The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Income-focused investors, long-term GEHC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling GEHC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best GE HealthCare Technologies Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile97.22% Elevated
- Market cap (M$)29,983
- 52 weeks high-26.06%
- 52 weeks low12.99%
- Analyst recommendationBuy
1.57 - Target price$82.78
24.71% above the current stock price - Dividend—
- Payout ratio3.08%
- Earnings date2026-11-04
- P/E15.25
- Future P/E12.21
- EPS (ttm)4.35
- EPS growth next 5 years9.56%
As of September 24, 2026
| 2026-09-25 | 2 | 68.00 | 2.89 | 0.05 | 0.25 | 196.00 | 2.97 | 541.23 | -0.08 | +0.16 | 177 | 0.20 |
| 2026-09-25 | 2 | 67.00 | 1.38 | 0.15 | 0.35 | 106.00 | 1.60 | 292.71 | -0.23 | +0.28 | 121 | 0.20 |
| 2026-10-16 | 23 | 75.00 | 13.48 | 0.05 | 0.20 | 896.00 | 13.56 | 215.15 | -0.08 | +0.06 | 764 | 0.15 |
| 2026-10-02 | 9 | 69.00 | 4.40 | 0.10 | 0.35 | 301.00 | 4.55 | 184.71 | -0.15 | +0.16 | 50 | 0.25 |
| 2026-10-30 | 37 | 77.00 | 16.51 | 0.05 | 0.75 | 1096.00 | 16.58 | 163.59 | -0.08 | +0.11 | 7 | 0.70 |
| 2026-10-16 | 23 | 72.50 | 9.70 | 0.10 | 0.75 | 651.00 | 9.85 | 156.32 | -0.15 | +0.15 | 1,206 | 0.65 |
| 2026-10-16 | 23 | 72.00 | 8.94 | 0.05 | 0.55 | 596.00 | 9.02 | 143.11 | -0.08 | +0.13 | 181 | 0.50 |
| 2026-10-09 | 16 | 70.00 | 5.92 | 0.20 | 0.45 | 411.00 | 6.22 | 141.87 | -0.30 | +0.17 | 15 | 0.25 |
| 2026-11-20 | 58 | 80.00 | 21.05 | 0.10 | 0.65 | 1401.00 | 21.20 | 133.40 | -0.15 | +0.10 | 10 | 0.55 |
| 2026-10-02 | 9 | 68.00 | 2.89 | 0.25 | 0.80 | 216.00 | 3.27 | 132.55 | -0.38 | +0.28 | 41 | 0.55 |
As of September 24, 2026
Sell covered calls with the data behind you
Find the best GEHC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→